Hexima Limited (HXL) Fair Value & Analysis
Financial Services · AU · Market cap A$543K
Fair value as of: Jun 26, 2026
From 1 valuation models · updated 3 days ago
Fair value updated Jun 26, 2026 — revised from A$0.1600 to A$0.0458 (−71.4%) since Jun 24, 2026.
Price vs Fair Value (12 months)
12‑month range A$0.0126 – A$0.0520 · fair‑value band A$0.0354 – A$0.0510 · the A$0.0520 price screens above the A$0.0458 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Hexima Limited (HXL) currently trades at A$0.0520, while our model-based Fair Value estimate is A$0.0458 — implying the stock looks roughly 12.0% overvalued today. We read business quality at 95/100 (high quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
It earns a return on equity of -15.1%. The balance sheet holds a net cash position of A$1.5M. Fundamentals as of Jun 26, 2026
Key figures & financial health
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
Hexima Limited does not have significant operations. It focuses on exploration of transactions with third parties, which could enable the value of the company's assets. Previously, the company was involved in the research and development of plant-derived proteins for applications as human therapeutics. Hexima Limited was incorporated in 1997 and is headquartered in Carlton, Australia.
Revenue & earnings trend
FY2019 – FY2025 · reported fiscal years
Hexima Limited reported revenue of A$1.5M in FY2023 versus A$798K in FY2019, a compound +16.8%/yr. Reported net income was −A$504K in FY2025.
Open the full interactive analysis →
Similar stocks
6 more Shell Companies stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Coca-Cola Company COLA | C$27.96 | C$10.91 | -61% |
| Lionheart III Corp LION | $13.69 | $4.49 | -67% |
| Agriculture & Natural Solutions Acquisition Corporation ANSC | $11.40 | $2.08 | -82% |
| AA Mission Acquisition Corp AAM | $0.0340 | $0.0500 | +47% |
| GP-Act III Acquisition Corp GPAT | $10.88 | $4.30 | -60% |
| Berto Acquisition Corp TACO | $10.40 | $11.08 | +7% |
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is Hexima Limited (HXL) undervalued?
What is the fair value of HXL?
What is the quality score of HXL?
What is the net profit margin of HXL?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.